TuHURA Biosciences, Inc.
- Last sale
- Nov 12, 2026 · -5.30%
- Market cap
- $94.03M
- 65.76M shares
- Filings
- 931
Q1 2026
Q3 2026N/M FY25 yoy
Q2 2013N/M FY12 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−71.4% FY25 yoy
- $94.03M
- —
- —
- 5.0×
- -29.46%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2012 | 2012-06-30 | $0 | reported | |
| FY 2011 | 2011-06-30 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $24.75K | $24.75K | — | 12.17M sh | −84.9% | — |
Pharmaceutical preparations
TuHURA Biosciences, Inc. is the 292nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
NRXPNRX Pharmaceuticals, Inc.$1.2M—2,336.5%$97.8MMSLESatellos Bioscience Inc.———$97.2MNBPNovaBridge Biosciences———$95.8MPLYXPolaryx Therapeutics, Inc.———$94.2M
HURATuHURA Biosciences, Inc. (this company)$0.0——$94.0M
ANIXAnixa Biosciences Inc———$93.2MPMVPPMV Pharmaceuticals, Inc.———$92.2MRACCResearch Alliance Corp III———$91.9MNKTXNkarta, Inc.$0.0——$90.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR